International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients
|ClinicalTrials.gov Identifier: NCT01111201|
Recruitment Status : Completed
First Posted : April 27, 2010
Last Update Posted : June 1, 2012
This study also aims to raise awareness among both patients and health-care providers about the importance of pre-travel health consultation and preventive interventions prior to international travel.
Through appropriate health counseling, cancer patients will have less risk of having travel -related health complications and thus have a better quality of life and overall improved sense of wellbeing.
|Condition or disease||Intervention/treatment|
|Breast Cancer Lymphoma||Behavioral: questionnaires|
|Study Type :||Observational|
|Actual Enrollment :||26 participants|
|Official Title:||Pilot Survey to Assess International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients at Memorial Sloan-Kettering Cancer Center|
|Study Start Date :||April 2010|
|Primary Completion Date :||March 2012|
|Study Completion Date :||March 2012|
There will be four versions of the questionnaire, each slightly modified to be more specific toward the treatment paradigms in the respective target patient population (Breast Cancer/ Lymphoma/Autologous Bone Marrow Transplant/ Allogeneic Bone Marrow Transplant). All questionnaire versions will consist of seven sections.
The intervention is a self-administered anonymous questionnaire that is voluntarily completed by the patient. Questions in Section One will cover general information about the patient including gender, age, race, country of birth, current zip code of residence, and level of education. Questions in Section Two will cover information regarding the cancer (breast/lymphoma) or transplant (allogeneic/ autologous). Questions in Section Three will cover travel history including the frequency of travel outside the United States and Canada in the last 5 years. Questions in Sections Four through Seven will obtain information about their last trip outside the United States and Canada.
- To determine the frequency of international travel of the targeted patients in the last 5 years. [ Time Frame: once at the time of the clinic visit ]
- To determine if any of the international travel was during a high-risk specific period when the immune status of the target population was compromised. [ Time Frame: once at the time of the clinic visit ]
- To profile the target population who traveled internationally with respect to their demographic and cancer/transplant-related characteristics. [ Time Frame: once at the time of the clinic visit ]
- To obtain detailed information about their last international trip including [ Time Frame: once at the time of the clinic visit ]
- To assess the adequacy of the questionnaire instructions [ Time Frame: once at the time of the clinic visit ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01111201
|United States, New York|
|Memorial Sloan Kettering Cancer Center|
|New York, New York, United States, 10065|
|Principal Investigator:||Monika Shah, MD||Memorial Sloan Kettering Cancer Center|